| Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia MA Barry, CA Behnke, A Eastman Biochemical pharmacology 40 (10), 2353-2362, 1990 | 1267 | 1990 |
| Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by Cisplatin CM Sorenson, MA Barry, A Eastman JNCI: Journal of the National Cancer Institute 82 (9), 749-755, 1990 | 619 | 1990 |
| Identification of deoxyribonuclease II as an endonuclease involved in apoptosis MA Barry, A Eastman Archives of Biochemistry and Biophysics 300 (1), 440-450, 1993 | 579 | 1993 |
| Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage libraries MA Barry, WJ Dower, SA Johnston Nature medicine 2 (3), 299-305, 1996 | 523 | 1996 |
| Lentiviral vectors: basic to translational T Sakuma, MA Barry, Y Ikeda Biochemical Journal 443 (3), 603-618, 2012 | 519 | 2012 |
| Poly (ethylenimine)‐mediated transfection: A new paradigm for gene delivery WT Godbey, MA Barry, P Saggau, KK Wu, AG Mikos Journal of Biomedical Materials Research: An Official Journal of The Society …, 2000 | 485 | 2000 |
| Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded R Cattaneo, T Miest, EV Shashkova, MA Barry Nature Reviews Microbiology 6 (7), 529-540, 2008 | 455 | 2008 |
| Protection against mycoplasma infection using expression-library immunization MA Barry, WC Lai, S Albert Johnston Nature 377 (6550), 632-635, 1995 | 441 | 1995 |
| Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo O Kalyuzhniy, NC Di Paolo, M Silvestry, SE Hofherr, MA Barry, PL Stewart, ... Proceedings of the National Academy of Sciences 105 (14), 5483-5488, 2008 | 407 | 2008 |
| Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification MA Barry, JE Reynolds, A Eastman Cancer Research 53 (10), 2349-2357, 1993 | 397 | 1993 |
| The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis? New Drugs A Eastman, MA Barry Cancer Investigation 10 (3), 229-240, 1992 | 371 | 1992 |
| Biological features of genetic immunization MA Barry, SA Johnston Vaccine 15 (8), 788-791, 1997 | 315 | 1997 |
| Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses H Mok, DJ Palmer, P Ng, MA Barry Molecular Therapy 11 (1), 66-79, 2005 | 299 | 2005 |
| Current advances and future challenges in Adenoviral vector biology and targeting SK Campos, MA Barry Current gene therapy 7 (3), 189-204, 2007 | 273 | 2007 |
| Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer KE Adams, S Ke, S Kwon, F Liang, Z Fan, Y Lu, K Hirschi, ME Mawad, ... Journal of biomedical optics 12 (2), 024017-024017-9, 2007 | 270 | 2007 |
| Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH MA Barry, A Eastman Biochemical and biophysical research communications 186 (2), 782-789, 1992 | 254 | 1992 |
| Interaction of trans-diamminedichloroplatinum (II) with DNA: formation of monofunctional adducts and their reaction with glutathione A Eastman, MA Barry Biochemistry 26 (12), 3303-3307, 1987 | 240 | 1987 |
| Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection ME Barry, D Pinto-Gonzalez, FM Orson, GJ McKenzie, GR Petry, MA Barry Human gene therapy 10 (15), 2461-2480, 1999 | 229 | 1999 |
| Advances and future challenges in adenoviral vector pharmacology and targeting R Khare, C Y. Chen, E A. Weaver, M A. Barry Current gene therapy 11 (4), 241-258, 2011 | 207 | 2011 |
| Semaphorin III can repulse and inhibit adult sensory afferents in vivo DL Tanelian, MA Barry, SA Johnston, T Le, GM Smith Nature medicine 3 (12), 1398-1401, 1997 | 173 | 1997 |
Antonios G. MikosProfessor of Bioengineering and Chemical and Biomolecular Engineering, Rice UniversityVerifierad e-postadress på rice.edu